NLRP3 and chronic obstructive pulmonary disease: This perception aligns with emerging evidence suggesting that beta-hydroxybutyrate (BHB), a key ketone body produced during ketosis, can inhibit the NLRP3 inflammasome—a critical component of chronic inflammation in COPD pathophysiology (33, 34).